Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant

Reactivation or primary infection with double-stranded DNA viruses is common in recipients of solid organ transplants (SOTs) and is associated with significant morbidity and mortality. Treatment with conventional antiviral medications is limited by toxicities, resistance, and a lack of effective opt...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of transplantation 2024-09, Vol.24 (9), p.1634-1643
Hauptverfasser:	Khoury, Ruby, Grimley, Michael S., Nelson, Adam S., Leemhuis, Tom, Cancelas, Jose A., Cook, Eleanor, Wang, YunZu, Heyenbruch, Daria, Bollard, Catherine M., Keller, Michael D., Hanley, Patrick J., Lutzko, Carolyn, Pham, Giang, Davies, Stella M., Rubinstein, Jeremy D.
Format:	Artikel
Sprache:	eng
Schlagworte:	adenovirus CMV EBV PTLD solid organ transplant viral reactivation virus-specific T cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!